| 1 | Structural analysis of an lysergic acid diethylamide (LSD) analogue <i>N</i>‐methyl‐<i>N</i>‐isopropyllysergamide (MiPLA): Insights from Rotamers in NMR spectra | 2.7 | 1 | Citations (PDF) |
| 2 | (3+2) Cycloaddition of Heteroaromatic <i>N</i>-Ylides with Sulfenes | 4.8 | 7 | Citations (PDF) |
| 3 | Development of STING degrader with double covalent ligands | 2.1 | 9 | Citations (PDF) |
| 4 | Photo-regulated PROTACs: A novel tool for temporal control of targeted protein degradation | 2.1 | 4 | Citations (PDF) |
| 5 | One-pot C(sp<sup>3</sup>)–H difluoroalkylation of tetrahydroisoquinolines and isochromans <i>via</i> electrochemical oxidation and organozinc alkylation | 3.4 | 5 | Citations (PDF) |
| 6 | Innovative peptide architectures: advancements in foldamers and stapled peptides for drug discovery | 4.5 | 12 | Citations (PDF) |
| 7 | Hydrophobic CPP/HDO conjugates: a new frontier in oligonucleotide-warheaded PROTAC delivery | 3.3 | 6 | Citations (PDF) |
| 8 | Strategic design of GalNAc-helical peptide ligands for efficient liver targeting | 7.1 | 5 | Citations (PDF) |
| 9 | Structure–Activity Relationship Studies of Substitutions of Cationic Amino Acid Residues on Antimicrobial Peptides | 4.3 | 13 | Citations (PDF) |
| 10 | Current Status of Oligonucleotide-Based Protein Degraders | 5.1 | 9 | Citations (PDF) |
| 11 | In silico optimization of peptides that inhibit Wnt/β-catenin signaling | 2.6 | 8 | Citations (PDF) |
| 12 | CRBN ligand expansion for hematopoietic prostaglandin D2 synthase (H-PGDS) targeting PROTAC design and their in vitro ADME profiles | 2.6 | 6 | Citations (PDF) |
| 13 | Synthesis and properties of PNA containing a dicationic nucleobase based on N4-benzoylated cytosine | 2.1 | 1 | Citations (PDF) |
| 14 | Development of versatile solid-phase methods for syntheses of PROTACs with diverse E3 ligands | 2.6 | 9 | Citations (PDF) |
| 15 | Development of DNA Aptamer-Based PROTACs That Degrade the Estrogen Receptor | 3.4 | 18 | Citations (PDF) |
| 16 | Identification of the Stapled α-Helical Peptide ATSP-7041 as a Substrate and Strong Inhibitor of OATP1B1 In Vitro | 4.4 | 3 | Citations (PDF) |
| 17 | Structure–Activity Relationship Study of Helix-Stabilized Antimicrobial Peptides Containing Nonproteinogenic Amino Acids | 5.4 | 12 | Citations (PDF) |
| 18 | Development of Hydrophobic Cell-Penetrating Stapled Peptides as Drug Carriers | 4.5 | 12 | Citations (PDF) |
| 19 | Enhancing Chemical Stability through Structural Modification of Antimicrobial Peptides with Non-Proteinogenic Amino Acids | 4.3 | 9 | Citations (PDF) |
| 20 | Magainin 2-derived stapled peptides derived with the ability to deliver pDNA, mRNA, and siRNA into cells | 7.1 | 10 | Citations (PDF) |
| 21 | Design of antimicrobial peptides containing non-proteinogenic amino acids using multi-objective Bayesian optimisation | 4.5 | 15 | Citations (PDF) |
| 22 | Structural Optimization of Decoy Oligonucleotide-Based PROTAC That Degrades the Estrogen Receptor | 3.9 | 9 | Citations (PDF) |
| 23 | Development of decoy oligonucleotide-warheaded chimeric molecules targeting STAT3 | 2.6 | 19 | Citations (PDF) |
| 24 | Sculpting Secondary Structure of a Cyclic Peptide: Conformational Analysis of a Cyclic Hexapeptide Containing a Combination of <scp>l</scp>-Leu, <scp>d</scp>-Leu, and Aib Residues | 4.3 | 1 | Citations (PDF) |
| 25 | The effects of magainin 2-derived and rationally designed antimicrobial peptides on Mycoplasma pneumoniae | 2.4 | 6 | Citations (PDF) |
| 26 | Development of Chimeric Molecules That Degrade the Estrogen Receptor Using Decoy Oligonucleotide Ligands | 3.4 | 27 | Citations (PDF) |
| 27 | Antiviral activity of ciclesonide acetal derivatives blocking SARS-CoV-2 RNA replication | 2.8 | 4 | Citations (PDF) |
| 28 | Helical Foldamers and Stapled Peptides as New Modalities in Drug Discovery: Modulators of Protein-Protein Interactions | 2.6 | 16 | Citations (PDF) |
| 29 | Control of STING Agonistic/Antagonistic Activity Using Amine-Skeleton-Based c-di-GMP Analogues | 4.5 | 3 | Citations (PDF) |
| 30 | Helix-Stabilized Cell-Penetrating Peptides for Delivery of Antisense Morpholino Oligomers: Relationships among Helicity, Cellular Uptake, and Antisense Activity | 3.9 | 18 | Citations (PDF) |
| 31 | Development of Rapid and Facile Solid‐Phase Synthesis of PROTACs via a Variety of Binding Styles | 2.6 | 21 | Citations (PDF) |
| 32 | Organocatalytic Synthesis of Phenols from Diaryliodonium Salts with Water under Metal-Free Conditions | 4.8 | 13 | Citations (PDF) |
| 33 | Structure–activity relationship study of PROTACs against hematopoietic prostaglandin D<sub>2</sub> synthase | 3.3 | 9 | Citations (PDF) |
| 34 | Recent Advances in PROTAC Technology Toward New Therapeutic Modalities | 2.3 | 5 | Citations (PDF) |
| 35 | Development of a penetratin-conjugated stapled peptide that inhibits Wnt/β-catenin signaling | 2.6 | 8 | Citations (PDF) |
| 36 | Development of Gilteritinib-Based Chimeric Small Molecules that Potently Induce Degradation of FLT3-ITD Protein | 3.4 | 18 | Citations (PDF) |
| 37 | Oligoarginine-Conjugated Peptide Foldamers Inhibiting Vitamin D Receptor-Mediated Transcription | 4.3 | 4 | Citations (PDF) |
| 38 | Amine skeleton-based c-di-GMP derivatives as biofilm formation inhibitors | 2.1 | 6 | Citations (PDF) |
| 39 | Development of Selective TGR5 Ligands Based on the 5,6,7,8‐Tetrahydro‐5,5,8,8‐tetramethylnaphthalene Skeleton | 3.1 | 6 | Citations (PDF) |
| 40 | Design and synthesis of novel estrogen receptor antagonists with acetal containing biphenylmethane skeleton | 3.6 | 0 | Citations (PDF) |
| 41 | Development of Antimicrobial Stapled Peptides Based on Magainin 2 Sequence | 4.3 | 47 | Citations (PDF) |
| 42 | Development of a Hematopoietic Prostaglandin D Synthase-Degradation Inducer | 3.4 | 29 | Citations (PDF) |
| 43 | Transition Metal-Free O-Arylation of Quinoxalin-2-ones with Diaryliodonium Salts | 0.4 | 1 | Citations (PDF) |
| 44 | Helical Antimicrobial Peptide Foldamers Containing Non‐proteinogenic Amino Acids | 3.1 | 31 | Citations (PDF) |
| 45 | Approach to Establishment of Control Strategy for Oral Solid Dosage Forms Using Continuous Manufacturing | 1.3 | 7 | Citations (PDF) |
| 46 | Changes in Test Methods for Internationalization in the Japanese Pharmacopoeia (Part 1): Establishment of a Quantitative Test Method for Clonidine Hydrochloride Using HPLC Analysis | 0.2 | 2 | Citations (PDF) |
| 47 | TRIP12 promotes small-molecule-induced degradation through K29/K48-branched ubiquitin chains | 13.4 | 95 | Citations (PDF) |
| 48 | Synthesis and characterization of PNA oligomers containing preQ1 as a positively charged guanine analogue | 2.1 | 5 | Citations (PDF) |
| 49 | Development of Agonist-Based PROTACs Targeting Liver X Receptor | 3.6 | 21 | Citations (PDF) |
| 50 | Miroestrol Quantification in <i>Pueraria mirifica</i> Crude Drugs and Products by Single-Reference UPLC/PDA/MS Using Relative Molar Sensitivities to Kwakhurin | 1.3 | 5 | Citations (PDF) |
| 51 | Structure–activity relationship study of amphipathic antimicrobial peptides using helix‐destabilizing sarcosine | 2.0 | 10 | Citations (PDF) |
| 52 | Development of ciclesonide analogues that block SARS-CoV-2 RNA replication | 2.1 | 3 | Citations (PDF) |
| 53 | Nickel-Catalyzed Hydrodeoxygenation of Aryl Sulfamates with Alcohols as Mild Reducing Agents | 2.3 | 6 | Citations (PDF) |
| 54 | 日本薬局方の国際化を目的とした各条の試験法変更に関する研究（第二報）：ロラゼパムのHPLCによる定量法設定に向けた検討 | 0.2 | 1 | Citations (PDF) |
| 55 | Peptide Stapling Improves the Sustainability of a Peptide-Based Chimeric Molecule That Induces Targeted Protein Degradation | 4.5 | 20 | Citations (PDF) |
| 56 | <i>N</i>-Nitrosodimethylamine (NDMA) Formation from Ranitidine Impurities: Possible Root Causes of the Presence of NDMA in Ranitidine Hydrochloride | 1.3 | 21 | Citations (PDF) |
| 57 | Discovery of non-proteinogenic amino acids inhibiting biofilm formation by S. aureus and methicillin-resistant S. aureus | 2.1 | 2 | Citations (PDF) |
| 58 | Synthesis of Norgestomet and its 17β-isomer and evaluation of their agonistic activities against progesterone receptor | 2.6 | 0 | Citations (PDF) |
| 59 | Discovery of a Highly Potent and Selective Degrader Targeting Hematopoietic Prostaglandin D Synthase via In Silico Design | 5.6 | 32 | Citations (PDF) |
| 60 | Fcγ Receptor-Dependent Internalization and Off-Target Cytotoxicity of Antibody-Drug Conjugate Aggregates | 3.8 | 62 | Citations (PDF) |
| 61 | Synthesis of Chiral α‐Trifluoromethyl α,α‐Disubstituted α‐Amino Acids and Conformational Analysis of L‐Leu‐Based Peptides with (<i>R</i>)‐ or (<i>S</i>)‐α‐Trifluoromethylalanine | 1.7 | 7 | Citations (PDF) |
| 62 | Design, Synthesis, and Biological Activity of Conformationally Restricted Analogues of Silibinin | 4.3 | 8 | Citations (PDF) |
| 63 | Rational Design of Helix‐Stabilized Antimicrobial Peptide Foldamers Containing α,α‐Disubstituted Amino Acids or Side‐Chain Stapling | 2.7 | 26 | Citations (PDF) |
| 64 | De Novo Design of Cell‐Penetrating Foldamers | 6.7 | 19 | Citations (PDF) |
| 65 | Design and synthesis of peptide-based chimeric molecules to induce degradation of the estrogen and androgen receptors | 2.6 | 11 | Citations (PDF) |
| 66 | Deubiquitylase USP25 prevents degradation of BCR-ABL protein and ensures proliferation of Ph-positive leukemia cells | 6.7 | 38 | Citations (PDF) |
| 67 | Targeted Protein Degradation by Chimeric Compounds using Hydrophobic E3 Ligands and Adamantane Moiety | 4.4 | 12 | Citations (PDF) |
| 68 | Copper‐Catalyzed Enantioselective Synthesis of Oxazolines from Aminotriols via Asymmetric Desymmetrization | 3.0 | 14 | Citations (PDF) |
| 69 | Selective Degradation of Target Proteins by Chimeric Small-Molecular Drugs, PROTACs and SNIPERs | 4.4 | 17 | Citations (PDF) |
| 70 | Critical role of mitochondrial ubiquitination and the OPTN–ATG9A axis in mitophagy | 5.5 | 185 | Citations (PDF) |
| 71 | Facile Synthesis of Kwakhurin, a Marker Compound of <i>Pueraria mirifica</i> and Its Quantitative NMR Analysis for Standardization as a Reagent | 1.3 | 5 | Citations (PDF) |
| 72 | Design and Synthesis of 4-(2-Pyrrolyl)-4-phenylheptane Derivatives as Estrogen Receptor Antagonists | 0.4 | 0 | Citations (PDF) |
| 73 | Inhibition of β-amyloid–induced neurotoxicity by planar analogues of procyanidin B3 | 2.1 | 12 | Citations (PDF) |
| 74 | Palladium-Catalyzed Synthesis of Deuterated Alkenes through Deuterodechlorination of Alkenyl Chlorides | 3.4 | 16 | Citations (PDF) |
| 75 | Development of Amphipathic Antimicrobial Peptide Foldamers Based on Magainin 2 Sequence | 3.1 | 23 | Citations (PDF) |
| 76 | Rapid and efficient high-performance liquid chromatography analysis of N-nitrosodimethylamine impurity in valsartan drug substance and its products | 3.5 | 55 | Citations (PDF) |
| 77 | Development of Small Molecule Chimeras That Recruit AhR E3 Ligase to Target Proteins | 3.7 | 99 | Citations (PDF) |
| 78 | Development of 2-aminoisobutyric acid (Aib)-rich cell-penetrating foldamers for efficient siRNA delivery | 3.4 | 29 | Citations (PDF) |
| 79 | Rational design of novel amphipathic antimicrobial peptides focused on the distribution of cationic amino acid residues | 4.6 | 18 | Citations (PDF) |
| 80 | Facile Synthesis of α‐<i>exo</i>‐Methylene Ketones from α,α‐Disubstituted Allyl Alcohols by Electrochemical Oxidative Migration | 2.9 | 9 | Citations (PDF) |
| 81 | Analysis of an Impurity, <i>N</i>-Nitrosodimethylamine, in Valsartan Drug Substances and Associated Products Using GC-MS | 1.6 | 32 | Citations (PDF) |
| 82 | Foldamer: Design, Conformation, and Function | 0.2 | 0 | Citations (PDF) |
| 83 | Design and synthesis of estrogen receptor ligands with a 4-heterocycle-4-phenylheptane skeleton | 2.6 | 5 | Citations (PDF) |
| 84 | Structural Development of Cell-Penetrating Peptides Containing Cationic Proline Derivatives | 1.3 | 12 | Citations (PDF) |
| 85 | Development of a Small Hybrid Molecule That Mediates Degradation of His-Tag Fused Proteins | 5.6 | 23 | Citations (PDF) |
| 86 | Structural development of non-secosteroidal vitamin D receptor (VDR) ligands without any asymmetric carbon | 2.6 | 0 | Citations (PDF) |
| 87 | Left-Handed Helix of Three-Membered Ring Amino Acid Homopeptide Interrupted by an N–H···Ethereal O-Type Hydrogen Bond | 4.8 | 9 | Citations (PDF) |
| 88 | Design and synthesis of cell-permeable fluorescent nitrilotriacetic acid derivatives | 2.6 | 2 | Citations (PDF) |
| 89 | Extent of Helical Induction Caused by Introducing α-Aminoisobutyric Acid into an Oligovaline Sequence | 4.3 | 12 | Citations (PDF) |
| 90 | Development of helix-stabilized cell-penetrating peptides containing cationic α,α-disubstituted amino acids as helical promoters | 2.6 | 27 | Citations (PDF) |
| 91 | Development of an ON/OFF switchable fluorescent probe targeting His tag fused proteins in living cells | 2.1 | 10 | Citations (PDF) |
| 92 | Efficient synthesis of a multi-substituted diphenylmethane skeleton as a steroid mimetic | 2.1 | 7 | Citations (PDF) |
| 93 | Design and synthesis of novel selective estrogen receptor degradation inducers based on the diphenylheptane skeleton | 4.6 | 11 | Citations (PDF) |
| 94 | Targeted Degradation of Proteins Localized in Subcellular Compartments by Hybrid Small Molecules | 2.7 | 48 | Citations (PDF) |
| 95 | Development of a peptide-based inducer of protein degradation targeting NOTCH1 | 2.1 | 25 | Citations (PDF) |
| 96 | Development of helix-stabilized antimicrobial peptides composed of lysine and hydrophobic α,α-disubstituted α-amino acid residues | 2.1 | 12 | Citations (PDF) |
| 97 | Simple and efficient knockdown of His-tagged proteins by ternary molecules consisting of a His-tag ligand, a ubiquitin ligase ligand, and a cell-penetrating peptide | 2.1 | 8 | Citations (PDF) |
| 98 | Rational Design and Synthesis of Post-Functionalizable Peptide Foldamers as Helical Templates | 3.9 | 8 | Citations (PDF) |
| 99 | Diastereomeric Right‐ and Left‐Handed Helical Structures with Fourteen (<i>R</i>)‐Chiral Centers | 3.4 | 11 | Citations (PDF) |
| 100 | Low pH-triggering changes in peptide secondary structures | 2.6 | 10 | Citations (PDF) |
| 101 | PNA monomers fully compatible with standard Fmoc-based solid-phase synthesis of pseudocomplementary PNA | 2.1 | 9 | Citations (PDF) |
| 102 | Helical <scp>l</scp>–Leu‐Based Peptides Having Chiral Five‐Membered Carbocyclic Ring Amino Acids with an Ethylene Acetal Moiety | 1.7 | 5 | Citations (PDF) |
| 103 | Tamoxifen and Fulvestrant Hybrids Showed Potency as Selective Estrogen Receptor Down-Regulators | 2.2 | 1 | Citations (PDF) |
| 104 | Identification of embryonic precursor cells that differentiate into thymic epithelial cells expressing autoimmune regulator | 9.4 | 51 | Citations (PDF) |
| 105 | The side‐chain hydroxy groups of a cyclic α,α‐disubstituted α‐amino acid promote oligopeptide 3<sub>10</sub>‐helix packing in the crystalline state | 2.9 | 1 | Citations (PDF) |
| 106 | Handedness Preferences of Heterochiral Helical Peptides Containing Homochiral Peptide Segments | 2.3 | 5 | Citations (PDF) |
| 107 | Synthesis of chiral five‐membered carbocyclic ring amino acids with an acetal moiety and helical conformations of its homo‐chiral homopeptides | 2.9 | 12 | Citations (PDF) |
| 108 | Plasmid DNA delivery by arginine-rich cell-penetrating peptides containing unnatural amino acids | 2.6 | 53 | Citations (PDF) |
| 109 | Synthesis and evaluation of raloxifene derivatives as a selective estrogen receptor down-regulator | 2.6 | 16 | Citations (PDF) |
| 110 | Development of a peptide-based inducer of nuclear receptors degradation | 2.1 | 26 | Citations (PDF) |
| 111 | Helical structures of homo-chiral isotope-labeled α-aminoisobutyric acid peptides | 2.0 | 6 | Citations (PDF) |
| 112 | Influence of L‐Leu to D‐Leu Replacement on the Helical Secondary Structures of L‐Leu‐Aib‐Based Dodecapeptides | 1.7 | 1 | Citations (PDF) |
| 113 | Peptide Nucleic Acid with a Lysine Side Chain at the β-Position: Synthesis and Application for DNA Cleavage | 1.3 | 3 | Citations (PDF) |
| 114 | Development of BCR-ABL degradation inducers via the conjugation of an imatinib derivative and a cIAP1 ligand | 2.1 | 120 | Citations (PDF) |
| 115 | Development of a Cell-penetrating Peptide that Exhibits Responsive Changes in its Secondary Structure in the Cellular Environment | 3.5 | 55 | Citations (PDF) |
| 116 | α‐Helical Structures of Oligopeptides with an Alternating l‐Leu‐Aib Segment | 2.3 | 13 | Citations (PDF) |
| 117 | A Helix‐Stabilized Cell‐Penetrating Peptide as an Intracellular Delivery Tool | 2.6 | 61 | Citations (PDF) |
| 118 | Effects of alkyl side chains and terminal hydrophilicity on vitamin D receptor (VDR) agonistic activity based on the diphenylpentane skeleton | 2.1 | 4 | Citations (PDF) |
| 119 | Effects of D-Leu Residues on the Helical Secondary Structures of L-Leu-Based Nonapeptides | 1.3 | 3 | Citations (PDF) |
| 120 | Synthesis and Evaluation of Novel Carbocyclic Oxetanocin A (COA-Cl) Derivatives as Potential Tube Formation Agents | 1.3 | 12 | Citations (PDF) |
| 121 | Peptide foldamers composed of six-membered ring α,α-disubstituted α-amino acids with two changeable chiral acetal moieties | 2.0 | 9 | Citations (PDF) |
| 122 | Design, synthesis, and anti-HIV-1 activity of 1-aromatic methyl-substituted 3-(3,5-dimethylbenzyl)uracil and <i>N</i>-3,5-dimethylbenzyl-substituted urea derivatives | 0.8 | 10 | Citations (PDF) |
| 123 | Synthesis and evaluation of tamoxifen derivatives with a long alkyl side chain as selective estrogen receptor down-regulators | 2.6 | 27 | Citations (PDF) |
| 124 | Design, synthesis, and anti-HIV-1 activity of 1-substituted 3-(3,5-dimethylbenzyl)triazine derivatives | 0.8 | 17 | Citations (PDF) |
| 125 | Structural development of stapled short helical peptides as vitamin D receptor (VDR)–coactivator interaction inhibitors | 2.6 | 24 | Citations (PDF) |
| 126 | A synthetic cannabinoid FDU-NNEI, two 2H-indazole isomers of synthetic cannabinoids AB-CHMINACA and NNEI indazole analog (MN-18), a phenethylamine derivative N–OH-EDMA, and a cathinone derivative dimethoxy-α-PHP, newly identified in illegal products | 1.9 | 44 | Citations (PDF) |
| 127 | Plasmid DNA delivery using fluorescein-labeled arginine-rich peptides | 2.6 | 28 | Citations (PDF) |
| 128 | Structural development of stabilized helical peptides as inhibitors of estrogen receptor (ER)-mediated transcription | 2.6 | 24 | Citations (PDF) |
| 129 | A preorganized β-amino acid bearing a guanidinium side chain and its use in cell-penetrating peptides | 2.6 | 41 | Citations (PDF) |
| 130 | Synthesis of a bis-cationic α,α-disubstituted amino acid (9-amino-bispidine-9-carboxylic acid) and its effects on the conformational properties of peptides | 2.0 | 12 | Citations (PDF) |
| 131 | Amino equatorial effect of a six-membered ring amino acid on its peptide 310- and α-helices | 2.0 | 10 | Citations (PDF) |
| 132 | Topological Study of the Structures of Heterochiral Peptides Containing Equal Amounts of <scp>l</scp>-Leu and <scp>d</scp>-Leu | 3.5 | 16 | Citations (PDF) |
| 133 | Development of Cell-Penetrating R7 Fragment-Conjugated Helical Peptides as Inhibitors of Estrogen Receptor-Mediated Transcription | 3.9 | 29 | Citations (PDF) |
| 134 | Design and synthesis of tamoxifen derivatives as a selective estrogen receptor down-regulator | 2.1 | 29 | Citations (PDF) |
| 135 | Conformational studies on peptides having chiral five-membered ring amino acid with two azido or triazole functional groups within the sequence of Aib residues | 2.0 | 8 | Citations (PDF) |
| 136 | Helical Peptide-Foldamers Having a Chiral Five-Membered Ring Amino Acid with Two Azido Functional Groups | 3.5 | 18 | Citations (PDF) |
| 137 | Amphipathic short helix-stabilized peptides with cell-membrane penetrating ability | 2.6 | 65 | Citations (PDF) |
| 138 | NAD-dependent isocitrate dehydrogenase as a novel target of tributyltin in human embryonic carcinoma cells | 3.5 | 32 | Citations (PDF) |
| 139 | Development of Stabilized Short Helical Peptides and Their Functionalization | 0.2 | 0 | Citations (PDF) |
| 140 | Synthesis and evaluation of novel 3-(3,5-dimethylbenzyl)uracil analogs as potential anti-HIV-1 agents | 2.6 | 19 | Citations (PDF) |
| 141 | Development of hybrid small molecules that induce degradation of estrogen receptor‐alpha and necrotic cell death in breast cancer cells | 4.0 | 122 | Citations (PDF) |
| 142 | Development of stapled short helical peptides capable of inhibiting vitamin D receptor (VDR)–coactivator interactions | 2.1 | 23 | Citations (PDF) |
| 143 | Oligopeptides with Equal Amounts of <scp>l</scp>- and <scp>d</scp>-Amino Acids May Prefer a Helix Screw Sense | 3.5 | 20 | Citations (PDF) |
| 144 | Helical Oligomers with a Changeable Chiral Acetal Moiety | 2.3 | 10 | Citations (PDF) |
| 145 | Helical Structures of Bicyclic <i>α</i>‐Amino Acid Homochiral Oligomers with the Stereogenic Centers at the Side‐Chain Fused‐Ring Junctions | 1.8 | 17 | Citations (PDF) |
| 146 | Solid-Phase Nucleophilic Fluorination | 1.7 | 4 | Citations (PDF) |
| 147 | Conformations of helical Aib peptides containing a pair of <scp>l</scp>‐amino acid and <scp>d</scp>‐amino acid | 2.0 | 18 | Citations (PDF) |
| 148 | Design and synthesis of estrogen receptor degradation inducer based on a protein knockdown strategy | 2.1 | 84 | Citations (PDF) |
| 149 | Monoallylation of 1,2‐Diols by Pd/Sn Bimetallic Catalysis | 3.4 | 12 | Citations (PDF) |
| 150 | One‐Handed Helical Screw Direction of Homopeptide Foldamer Exclusively Induced by Cyclic α‐Amino Acid Side‐Chain Chiral Centers | 3.4 | 52 | Citations (PDF) |
| 151 | Conformational studies on peptides containing α,α-disubstituted α-amino acids: chiral cyclic α,α-disubstituted α-amino acid as an α-helical inducer | 2.6 | 69 | Citations (PDF) |
| 152 | Identification of Mutaprodenafil in a Dietary Supplement and Its Subsequent Synthesis | 1.3 | 17 | Citations (PDF) |
| 153 | Design, synthesis and X-ray crystallographic study of new nonsecosteroidal vitamin D receptor ligands | 2.1 | 22 | Citations (PDF) |
| 154 | β-PNA: Peptide nucleic acid (PNA) with a chiral center at the β-position of the PNA backbone | 2.1 | 29 | Citations (PDF) |
| 155 | Effect of one D‐Leu residue on right‐handed helical ‐L‐Leu‐Aib‐ peptides in the crystal state | 2.0 | 10 | Citations (PDF) |
| 156 | Screw‐Sense Control of Helical Oligopeptides Containing Equal Amounts of <scp>L</scp>‐ and <scp>D</scp>‐Amino Acids | 3.4 | 27 | Citations (PDF) |
| 157 | Enantioselective epoxidation of α,β-unsaturated ketones catalyzed by stapled helical l-Leu-based peptides | 2.0 | 49 | Citations (PDF) |
| 158 | Design of a stabilized short helical peptide and its application to catalytic enantioselective epoxidation of (E)-chalcone | 1.4 | 26 | Citations (PDF) |
| 159 | Facile Synthesis of Stereoisomers of the Non-Secosteroidal Ligand LG190178 and their Evaluation Using the Mutant Vitamin D Receptor | 0.9 | 8 | Citations (PDF) |
| 160 | Solid-state conformation of diastereomeric -Pro-Pro-(Aib)4 sequences | 2.0 | 16 | Citations (PDF) |
| 161 | Facile synthesis of optically active oxindoles by copper-catalyzed asymmetric monotosylation of prochiral 1,3-diols | 1.6 | 14 | Citations (PDF) |
| 162 | Controlling the helical screw sense of peptides with <i>C</i>‐terminal L‐valine | 2.0 | 20 | Citations (PDF) |
| 163 | Conformations of peptides containing a chiral cyclic α, α‐disubstituted α‐amino acid within the sequence of Aib residues | 2.0 | 27 | Citations (PDF) |
| 164 | Three-Dimensional Structural Control of Diastereomeric Leu-Leu-Aib-Leu-Leu-Aib Sequences in the Solid State | 3.5 | 19 | Citations (PDF) |
| 165 | Nonenzymatic kinetic resolution of racemic α-hydroxyalkanephosphonates with chiral copper catalyst | 1.4 | 14 | Citations (PDF) |
| 166 | Helical-Screw Directions of Diastereoisomeric Cyclic α-Amino Acid Oligomers | 4.8 | 27 | Citations (PDF) |
| 167 | Ring Contraction of α,β-Unsaturated Cyclic Amines with cis-Dihydroxylation at the α,β-Position | 0.4 | 4 | Citations (PDF) |
| 168 | Direct electrochemical α-cyanation of N-protected cyclic amines | 2.6 | 53 | Citations (PDF) |
| 169 | Convenient synthesis of an enantiomerically pure bicyclic proline and its N-oxyl derivatives | 1.6 | 24 | Citations (PDF) |
| 170 | Effecient Kinetic Resolution of Racemic Amino Aldehydes by Oxidation with <i>N</i>‐Iodosuccinimide | 14.4 | 47 | Citations (PDF) |
| 171 | Effecient Kinetic Resolution of Racemic Amino Aldehydes by Oxidation with <i>N</i>‐Iodosuccinimide | 1.4 | 14 | Citations (PDF) |
| 172 | High regioselectivity in electrochemical α-methoxylation of N-protected cyclic amines | 2.0 | 34 | Citations (PDF) |
| 173 | Asymmetric electrochemical oxidation of 1,2-diols, aminoalcohols, and aminoaldehydes in the presence of chiral copper catalyst | 2.0 | 51 | Citations (PDF) |
| 174 | Diastereoselective arylation of l-proline derivatives at the 5-position | 2.0 | 34 | Citations (PDF) |
| 175 | Efficient oxidation of alcohols electrochemically mediated by azabicyclo-N-oxyls | 1.4 | 76 | Citations (PDF) |
| 176 | Chiral azabicyclo-N-oxyls mediated enantioselective electrooxidation of sec-alcohols | 1.4 | 63 | Citations (PDF) |
| 177 | Oxidative C–C bond cleavage of N-alkoxycarbonylated cyclic amines by sodium nitrite in trifluoroacetic acid | 1.4 | 19 | Citations (PDF) |
| 178 | Regioselective Protection of Sugars Catalyzed by Dimethyltin Dichloride | 4.8 | 133 | Citations (PDF) |
| 179 | Regioselective Introduction of Electrophiles into Piperidine Derivatives at the 4-Position | 0.4 | 14 | Citations (PDF) |
| 180 | Controlling 310-Helix and .ALPHA.-Helix of Short Peptides in the Solid State | 1.3 | 43 | Citations (PDF) |
| 181 | Lipase-Catalyzed Kinetic Resolution of Cyclic <i>trans</i>-1,2-Diols Bearing a Diester Moiety: Synthetic Application to Chiral Seven-Membered-Ring α,α-Disubstituted α-Amino Acid | 3.5 | 12 | Citations (PDF) |
| 182 | Antiviral Activity of 3-(3,5-Dimethylbenzyl)Uracil Derivatives Against Hiv-1 and HCMV | 1.6 | 11 | Citations (PDF) |
| 183 | Copper complex catalyzed asymmetric monosulfonylation of meso-vic-diols | 1.4 | 59 | Citations (PDF) |
| 184 | Asymmetric oxidation of 1,2-diols using N-bromosuccinimide in the presence of chiral copper catalyst | 1.4 | 92 | Citations (PDF) |
| 185 | Asymmetric tosylation of racemic 2-hydroxyalkanamides with chiral copper catalyst | 1.4 | 44 | Citations (PDF) |
| 186 | Synthesis of 6-Arylthio Analogs of 2′,3′-Dideoxy-3′-Fluoroguanosine and Their Effect against Hepatitis B Virus Replication | 1.6 | 4 | Citations (PDF) |
| 187 | Synthesis and Anti-HIV-1 and Anti-HCMV Activity of 1-Substituted 3-(3,5-Dimethylbenzyl)uracil Derivatives | 1.3 | 25 | Citations (PDF) |
| 188 | Electrochemical Oxidation of L-Prolinol Derivative Protected with 1-Alkoxy-2,2,2-trifluoroethyl Group | 1.3 | 13 | Citations (PDF) |
| 189 | Kinetic resolution of vic-amino alcohols catalyzed by a chiral Cu(II) complex | 1.4 | 25 | Citations (PDF) |
| 190 | Asymmetric desymmetrization of meso-vic-diols by carbamoylation catalyzed with a chiral Cu(II) complex | 1.4 | 37 | Citations (PDF) |
| 191 | Reaction of O6-methylguanosine with nitrite in the presence of carboxylic acid: synthesis of the purin-2-yl carboxylate | 1.4 | 10 | Citations (PDF) |
| 192 | Side-Chain Chiral Centers of Amino Acid and Helical-Screw Handedness of Its Peptides | 15.0 | 44 | Citations (PDF) |
| 193 | Chiral Centers in the Side Chains ofα-Amino Acids Control the Helical Screw Sense of Peptides | 14.4 | 57 | Citations (PDF) |
| 194 | Chiral Centers in the Side Chains ofα-Amino Acids Control the Helical Screw Sense of Peptides | 1.4 | 9 | Citations (PDF) |
| 195 | Asymmetric ring cleavage reaction with a combination of optically active cycloalkane-1,2-diol and Lewis acid: application to formal synthesis of (−)-alloyohimbane and approach to construction of adjacent chiral quaternary centers | 2.0 | 5 | Citations (PDF) |
| 196 | An Extended Planar C5 Conformation and a 310-Helical Structure of Peptide Foldamer Composed of Diverse -Ethylated ,-Disubstituted -Amino Acids | 3.4 | 42 | Citations (PDF) |
| 197 | Linker and Conjugation Site Synergy in Antibody–Drug Conjugates: Impacts on Biological Activity | 3.9 | 2 | Citations (PDF) |
